相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
Rita Chiari et al.
CLINICAL LUNG CANCER (2020)
Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis
Aurelien Delluc et al.
HAEMATOLOGICA (2020)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
A. J. Munoz Martin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m)
Andrea Marshall et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism
Robert A. Schmidt et al.
THROMBOSIS RESEARCH (2020)
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
Frits Mulder et al.
BLOOD (2020)
A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer
Marliese Alexander et al.
LUNG CANCER (2020)
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study
Saroj Vadhan-Raj et al.
CANCER MEDICINE (2020)
Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
Isabelle Mahe et al.
CANCERS (2020)
Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Corinne Frere et al.
CANCERS (2020)
High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1
Nerea Munoz-Unceta et al.
EUROPEAN JOURNAL OF CANCER (2020)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid
Harsh K. Patel et al.
CURRENT ONCOLOGY REPORTS (2019)
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study
Marcello Di Nisio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer
Jon Zugazagoitia et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH
B. T. Samuelson Bannow et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous ThromboembolismAnalysis of the CATCH Study
Rupert Bauersachs et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Treatment algorithm in cancer-associated thrombosis: Canadian expert consensus
M. Carrier et al.
CURRENT ONCOLOGY (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
Daniel M. Witt et al.
BLOOD ADVANCES (2018)
Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality
Tyson E. Turner et al.
JAMA NETWORK OPEN (2018)
Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours
Chatree Chai-Adisaksopha et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study
Luis Jara-Palomares et al.
THROMBOSIS RESEARCH (2017)
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy
Sam Schulman
BLOOD (2017)
ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism
Alona Zer et al.
CLINICAL LUNG CANCER (2017)
Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial
Fergus Macbeth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
Jessica Donato et al.
BLOOD (2015)
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
Uwe Pelzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12months: the DALTECAN Study
C. W. Francis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study
Ilana Kopolovic et al.
ANNALS OF HEMATOLOGY (2015)
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study
Mariasanta Napolitano et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis
Ryma Ihaddadene et al.
THROMBOSIS RESEARCH (2014)
Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer
Sylvia K. Haas et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2012)
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
A. Maraveyas et al.
EUROPEAN JOURNAL OF CANCER (2012)
Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis
Sonia Seng et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis
Tracy Proverbs-Singh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads
F. Scotte et al.
SUPPORTIVE CARE IN CANCER (2012)
High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis
Russell A. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of Methods
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2010)
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
J. R. Perry et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Understanding and managing the possible adverse effects associated with bevacizumab
Stacy S. Shord et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group
Naureen Starling et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Incidence and management of bevacizumab-related toxicities in colorectal cancer
M. Wasif Saif et al.
EXPERT OPINION ON DRUG SAFETY (2006)
分享论文
